Related Experiment Video

Updated: Sep 25, 2026

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation
11:06

Genome-wide Analysis of HDAC Inhibitor-mediated Modulation of microRNAs and mRNAs in B Cells Induced to Undergo Class-switch DNA Recombination and Plasma Cell Differentiation

Published on: September 20, 2017

HLA-A and DPB1 loci confer susceptibility to Graves' disease

R P Dong1, A Kimura, R Okubo

  • 1Department of Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

Human Immunology
|November 1, 1992
PubMed

Insights

This study identifies specific Human Leukocyte Antigen (HLA) alleles associated with Graves' disease in Japan. HLA-A2 and DPB1*0501 alleles show a significant synergistic effect, increasing the risk of developing this autoimmune condition.

Area of Science:

  • Immunogenetics
  • Human Leukocyte Antigen (HLA) complex
  • Autoimmune diseases

Background:

  • Graves' disease is an autoimmune disorder affecting the thyroid gland.
  • Human Leukocyte Antigen (HLA) genes are known to influence susceptibility to autoimmune diseases.
  • Previous studies suggest a role for HLA alleles in Graves' disease pathogenesis, but specific associations require further investigation.

Purpose of the Study:

  • To investigate the association between specific Human Leukocyte Antigen (HLA) alleles and the pathogenesis of Graves' disease in a Japanese population.
  • To identify potential genetic risk factors within the HLA system contributing to Graves' disease development.

Main Methods:

  • Serologic typing was used to examine HLA-A, B, C, DR, and DQ specificities.
  • DNA typing utilizing the PCR-SSOP method was employed to analyze HLA-DPB1 alleles.
  • Case-control study involving 76 Graves' disease patients and 317 healthy controls from the Japanese population.

Main Results:

  • Increased frequencies of HLA-A2, B46, Cw11, and DPB1*0501 were observed in patients compared to controls.
  • Statistically significant increases in HLA-A2 (p<0.02) and DPB1*0501 (p<0.002) were confirmed after applying corrected p-values.
  • Individuals with both DPB1*0501 and HLA-A2 exhibited the highest odds ratio (OR) of 10.5 for developing Graves' disease, suggesting a synergistic effect.

Conclusions:

  • The Human Leukocyte Antigen (HLA) class I allele HLA-A2 and the HLA class II allele DPB1*0501 are significantly associated with Graves' disease in the Japanese population.
  • A synergistic interaction between HLA-A2 and DPB1*0501 appears to play a crucial role in the pathogenesis of Graves' disease.
  • These findings highlight the importance of specific HLA alleles as genetic determinants in the development of Graves' disease.

More Related Videos

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment07:26

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation08:07

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation

Published on: September 6, 2017

Related Concept Videos

Genetic Lingo02:25

Genetic Lingo

An organism is diploid if it inherits two variants, or alleles, of each gene, one from each parent. These two alleles constitute the genotype for a given gene. The term genotype is also used to refer to an organism’s complete set of genes. A diploid organism with two identical alleles has a homozygous genotype, whereas two different alleles indicate a heterozygous genotype. Observable traits arising from genotypes are called phenotypes, which can also be influenced by environmental factors. An...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...